Table 5.
Cost-effectiveness results for a cohort of 1000 patients, where those undergoing PCI have stopped all anti-anginal medical therapy
Treatment | Total costs | Total QALYs | Cost difference | QALY difference | ICER |
Placebo | £410 405 | 796.092 | |||
PCI | £1 913 852 | 813.661 | £1 503 447 | 17.569 | £85 576* |
*ICER calculated prior to rounding.
ICER, incremental cost-effectiveness ratio; PCI, percutaneous coronary intervention; QALYs, quality-adjusted life-years.